Safety Alerts & Recalls

What does this mean?

This recall for Semprex-D capsules was issued at a warehouse and pharmacy level only. The FDA and the companies involved have determined that any recalled product that may have been dispensed to patients does not pose a significant health risk. If you take Semprex-D and are concerned, you should follow up with your doctor.

UCB Manufacturing, Inc and DSM Pharmaceuticals, Inc Recall Two Lots of Semprex-D Capsules

UCB Manufacturing, Inc and DSM Pharmaceuticals, Inc have issued a recall for two lots of Semprex-D capsules (8 mg acrivastine/60 mg pseudoephedrine hydrochloride). Lot numbers A43528 and A43529 are being recalled because because samples from these lots did not pass the manufacturer's routine tests for impurities and by-products from chemical breakdown over time.

Semprex-D contains the active ingredients acrivastine and pseudoephedrine and is commonly used in the treatment of sneezing, cough, runny or stuffy nose, itchy or watery eyes, hives, skin rash, itching, and other symptoms of allergies and the common cold. This recall alert only applies to the select lots of Semprex-D capsules (8 mg acrivastine/60 mg pseudoephedrine hydrochloride). No other acrivastine and pseudoephedrine products were involved in this recall.

To view the FDA notice about this recall, please visit: more information here

Source: FDA
Publication Date: 2010-06-11
Last Updated: 2010-06-11

Visit the medication page for the following drugs:

Share your story Share your story! Tell us how MediGuard has helped you or someone you love. Mobile graphic Download the MediGuard Mobile App to manage your prescription and over-the-counter medications, for free. Registration Info Taking multiple medications puts you at risk for possible drug-drug interactions Registration Info Monitor the medical treatment of you and your loved ones.